[105 Pages Report] The fractional flow reserve market is projected to reach USD 1,082 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period.
The study involved four major activities in estimating the current market size for fractional flow reserve market. Exhaustive secondary research was done to collect information about the market, peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Thirdly, both top-down and bottom-up approaches were employed to estimate the complete market size. Finally, the market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Growth in this market is primarily attributed to the rising geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR.
Primary Research:
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the fractional flow reserve market. The primary sources from the demand side include personnel from interventional cardiologists, research organizations, academic institutes, and purchase managers.
- A robust primary research methodology has been adopted to validate the contents of the report
- Both telephonic and e-mail interviews of primary participants were conducted through questionnaires
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=257837023
Report Objectives in Detailed:
- To define, describe, and forecast the fractional flow reserve market by technology, application, and region
- To provide detailed information regarding factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
By technology, the invasive monitoring segment is estimated to hold the largest share of the fractional flow reserve market
Based on technology, the fractional flow reserve market is segmented into invasive and non-invasive monitoring. The invasive monitoring segment accounted for the largest share of the market in 2018. The large share of this segment can be attributed to the strong recommendation for FFR usage in coronary angiography by the American College of Cardiology, American Heart Association, European Society of Cardiology (ESC), and the European Association for Cardio-Thoracic Surgery (EACTS).
Pressure Guidewires to dominate fractional flow reserve market during the forecast period
On the basis of type, the invasive monitoring market is segmented into pressure guidewires and FFR monitoring systems. The pressure guidewires segment accounted for the larger market share in 2018. This can be attributed to the growth in the number of PCI procedures (as a result of the rising prevalence of CVD), strong recommendation for guided revascularization by measuring FFR in specific clinical scenarios, and the single-use nature of pressure guidewires.
Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=257837023
North America is expected to hold the largest market share during the forecast period
North America is the major revenue-generating region in the fractional flow reserve market. The fractional flow reserve market in the region is driven by high healthcare spending in the region, rising prevalence of CVD and lifestyle diseases, growth in the geriatric population, a large number of ongoing research activities and product launches, availability of reimbursements, and the rapid adoption of technologically advanced imaging systems.
Key Market Players
The key players in the fractional flow reserve industry are Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands)
